Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1387508 NEW YORK, NY

Position in BMRN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$331,818
+$43,850 QoQ
Shares Held
5,799
+9.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#374
of 561 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Sep 30, 2020
CallValue
$22,824
CallShares
300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $41,687,806 across 71 Biotechnology names. BMRN ranks #23 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BMRN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $331,818 5,799
2025-09-30 $287,968 5,317
2023-06-30 $1,324,643 15,282
2023-03-31 $1,432,150 14,728
2022-12-31 $1,517,577 14,664
2022-09-30 $306,189 3,612
2022-06-30 $810,634 9,782
2020-12-31 $623,037 7,105
2020-09-30 $22,824 300
2020-06-30 $515,191 4,177
2020-06-30 $49,336 400
2020-03-31 $250,796 2,968